Reproductive Health and Disease - Lecture 2 Infertility 02.02.23 For Moodle

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 136

Reproductive health and

disease, Part II
Dr Sarah Arrowsmith
s.arrowsmith@mmu.ac.uk

Phone 0161 247 1177


Room JD E228
Advanced Biological Aspects of Disease
Lecture 2 overview:
• Male factor infertility
• Sperm, testes and tubes

• Disorders of uterine function in pregnancy


• Physiological basis of uterine contraction
• Adenomyosis
• Aetiology of preterm birth, its prevention and treatment
• Aetiology of dysfunctional labour and postpartum haemorrhage and
treatment
Learning outcomes:
At the end of this lecture you should be able to:

1. Describe the physiological principles of male reproduction


2. Describe different factors contributing to male infertility
3. Explain how these factors can cause infertility (mechanism)
4. Identify and propose treatment strategies
5. Describe the physiological mechanisms which underlie uterine contractions
6. Explain the aetiology of different uterine contraction disorders and their
treatment
Male factor infertility accounts for ~40% of the cause of
infertility

Other
Chryptorchidism 7%
6%
Obstruction
6%
varicocele
Testicular failure 37%
9%

Semen disorders idiopathic


10% 25%
Investigating male infertility

• Diminished Sperm Count & Quality

• Tubal problems (Ductus deferens)

• Reproductive pathology

• Erectile dysfunction

• Problems ejaculating
Male reproductive system
Male Reproductive system

Quick Quiz

5.

4.

1.
2.

3.
6.
Testis
Spermatogenesis
• Begins at puberty until ~70 years
• ~64 day process

Mitosis

1st meiotic division

Meiosis
2nd meiotic division

Spermiogenesis
Seminiferous Tubles
Spermatogenesis
(nurse cell)

Seminiferous tubule
lumen
Spermatogenesis

Section through the seminiferous tubules of the testes


Role of Sertoli cells
• Provide a protective barrier between seminiferous tubules and
general circulation
- maintain stable conditions in lumen, protection from immune
system
• Produce fluid in lumen and regulate its composition
• Site of action for control of spermatogenesis by testosterone and FSH
• Provide nourishment for sperm for development
• Engulf cytoplasm extruded from spermatids during remodelling
• Secrete inhibin  -ve feedback of FSH release
Spermatozoa
Endocrine control of male reproduction

• Controlled by hormones from the


hypothalamus, anterior pituitary
and testes GnRH
• GnRH
• Follicle Stimulating Hormone
• Luteinizing Hormone FSH LH

• Inhibin
• Testosterone Testosterone
Inhibin
Activin
Endocrine control of male reproduction

• Controlled by hormones from the


Hypothalamus
hypothalamus, anterior pituitary
and testes Gonadotrophin Releasing Hormone
• GnRH
• Follicle Stimulating Hormone
• Luteinizing Hormone
FSH LH
Hormonal regulation of spermatogenesis

• Controlled by hormones from the


Hypothalamus
hypothalamus, anterior pituitary
and testes Gonadotrophinreleasing
Gonadotrophin Releasinghormone
Hormone Negative
• GnRH feedback

• Follicle Stimulating Hormone


• Luteinizing Hormone
FSH LH
• Inhibin Negative
feedback
• Testosterone

inhibin testosterone
Role of testosterone

• Promotes spermatogenesis
• Establishes and maintains male secondary sex characteristics
• Maintains accessory glands and organs of the male reproductive
system
• Stimulates muscle and bone growth
• Drives and maintains sexual behaviours
• Feedback to the hypothalamus to regulate its own release
(negative feedback)
Bringing it all together
Investigating male infertility

• Diminished Sperm Count & Quality

• Tubal problems (Ductus deferens)

• Reproductive pathology

• Erectile dysfunction

• Problems ejaculating
What is ‘normal’ sperm?

WHO 2010
WHO 2021
Semen analysis
Andrology Report
Original 2010:
Semen samples from over 4500 men in 14 countries on Semen volume: 1.4mL
four continents were obtained from retrospective and
Sperm Number : 39 x 106
prospective analyses on fertile men:

Men whose partners had a time-to-pregnancy (TTP) of Progressive


12 months Motility: 30%

Provided reference distributions for semen parameters Morphology


(normal forms): 4%
6th Ed – addition of 3500 more men in 12 countries
across 5 continents ( more global picture) Vitality: 54%

*lower reference limits,


fifth centile (95%)
Sperm Count, Motility & Morphology – Terminology!

Oligoasthenoteratozoospermia (OAT)

Oligozoospermia: Low sperm concentration Most common


cause of male
subfertility
Asthenozoospermia: Poor motility and/or forward progression

Teratozoospermia: Reduced percentage of morphologically normal sperm

Normozoospermia: Normal semen parameters

Azoospermia: No spermatozoa found in semen

Necrozoospermia: No live sperm in semen

Globozoospermia: Round headed acrosome-less sperm


Count

Sperm Conc. 15 million /


ml
Morphology
Other Measures of Sperm Health

DNA
Maturity:
fragmentation:
Hyaluronan –
COMET Assay
Binding Assay

Origio.com

DNA
fragmentation:
Sperm
Chromatin
Dispersion
‘halo’
Computer aided sperm analysis- technique
CASA Majzoub et al Asian Journal of Andrology (2016) 18, 205–212

Sperm motility (progressive)


Causes of low sperm count and quality
Decline in Male Fertility

A global 50% decline


in sperm counts in
men over the previous
50 years (1992)

‘There has been a genuine decline in semen quality over the past 50 years’

Carlsen et al, 1992 https://doi.org/10.1136/bmj.305.6854.609


50-60% decline in sperm concentration between 1973 and 2011 in men from around the world (2017).
Dramatic decline in sperm concentration and overall
count over the last 40 years
The proportion of men with a normal total motile sperm
count declined by approximately 10% over the previous 16
years

Tiegs, AW, Total Motile Sperm Count Trend Over Time: Evaluation of Semen Analyses From 119,972 Men From Subfertile Couples,
Urology, Volume 132, 2019, Pages 109-116
Men today produce fewer sperm
than in the past, and the sperm are
less healthy

But why?
Lifestyle and Environmental Exposures

Content Header
Philos Trans R Soc Lond B Biol Sci. 2010;365(1546):1697-712
Testicular Dysgenesis Syndrome

• Bisphenol A
• Hypospadias
• Dibutyl phthalate
‘androgen • Cryptorchidism
• Phenols
• Poor semen quality
disruptors’ • Pesticides
• Testicular cancer
• Smoking / Alcohol

Environmental and genomic factors could affect the development of the male reproductive system in utero
Environ Health Perspect. 2007 Oct;115(10):1519-26.

Male development and


reproductive toxicity
Decreased anogenital
distance
Histological damage to
testes
Apoptosis of
seminiferous tubule cells
Lifestyle and Environmental Exposures in the Adult
Urinary:

• Mono-[2-(carboxymethyl) hexyl] phthalate (MCMHP)


• Lower total sperm counts & concentrations
• Mono-(2-ethyl-5- hydroxyhexyl) phthalate (MEHHP) Significantly
• Abnormal morphology
• Mono-benzyl phthalate (MBzP), associated
• Lower sperm motility
• Mono-isononyl phthalate (MNP)
• Mono-methyl phthalate (MMP)
• Mono-cyclohexyl phthalate (MCPP)
Obesity - Smoking - Diet - Diabetes

Glycation

Covalent attachment of sugar to a protein or lipid

Advanced glycation end product


Advanced Glycation Endproducts

1. Amino group of a protein


reacts with a carbonyl group of
a reducing sugar

2. Production of Schiff base


and Amadori products
- Reversible

3. Dehydration and
oxidation produces The amount of product
stable AGEs is dependent on the
concentration of glucose
so hyperglycaemia
accelerates AGE
production
Zhu, Life Sciences 2020
Consequences of AGEs

Zhu, Life Sciences 2020


Main Causes of Male Infertility

Genetics

Endocrinopathies

Varicocele

Infections and injury


Varicocele
• Enlargement of the veins in the scrotum
• Increased hydrostatic pressure in
intrascrotal pampiniform plexus and
testicular venules

• Diagnosed by physical examination and


confirmed by Doppler ultrasonography

• Found in ~15% of all males

• Most common cause of male infertility


~ 30-60%

• Present with oligoasthenoteratozoospermia


Varicocele

....is related to semen abnormalities,


decreased testicular volume and decline in Leydig cell function

Exacerbated by smoking and by infection or inflammation of the


accessory glands

Treatment:
Microsurgery Varicocelectomy
Infection
Genitourinary tract infections such as:

Urethritis
Epididmyitis
Orchitis
Prostatitis
Male Accessory Gland Infection (MAGI)

Urethritis
Infection
Microbiological cause:

Candida spp Neisseria gonorrhoeae


Chlamydia trachomatis
Trichomonas vaginalis STI
Ureaplasma urealyticum
Neisseria gonorrhoeae

Enterobacteriaceae spp
Streptococcus spp
Staphylococcus spp
Anaerobes
Infection
Epididymo-orchitis

An inflammation of the epididymis and/or testicle (testis)


Impact on fertility

• Changes in functional capacity of sperm –


Changes in membrane integrity
Reduced acrosome reactivity
Oxidative damage to DNA
Poor sperm motility (asthenozoospermia)
Low sperm count (oligozoospermia)

• Changes in semen biochemistry


• Decreased ejaculate volume
• High concentration of Reactive Oxygen Species (ROS)

• Affecting female fertility - male accessory glands may function as a reservoir for
pathogens, increasing probability of infection in females
Injury
Injury
Acute trauma to the testicles or
testicular torsion can result in a breach
of the Blood Testis Barrier (BTB)

BTB : highly specialized tight junctions


(zonula occludens) between
neighbouring Sertoli

Restricts the passage of larger


hydrophilic molecules.

Exists to prevent reactions against


autoantigens associated with
spermatogenesis
Injury
Breach of the BTB through injury
infection or surgery can result in
autoimmune infertility

Antisperm antibodies (ASA) significantly


impairs sperm’s fertilizing capacity by
affecting:

• Sperm motility
• The acrosome reaction
• Penetration of the cervical mucus
• Binding to the zona pellucida
• Sperm–oocyte fusion
Congenital Factors

Klinefelter syndrome is the most common


sex chromosome disorder

1 in 600 new born males

Affected males carry an additional X


chromosome, which results in male
hypogonadism, androgen deficiency, and
impaired spermatogenesis.
Klinefelter syndrome

Characteristics: Treatments:

Abnormal body proportions Testosterone replacement therapy


Gynecomastia once puberty begins
Sparse pubic, armpit, and facial hair
Small, firm testicles
Tall height Fertility treatment e.g. artificial
Azoospermic / cryptozoospermic insemination or ICSI

Low testosterone levels Breast reduction surgery


Elevated estradiol
Elevates FSH
Anabolic Steroid Use

Prolonged use of anabolic steroids induces


reversible Hypogonadotrophic Hypogonadism

Decreased serum testosterone, testicular


atrophy and impaired spermatogenesis

- Azoospermia

Why?
Anabolic Steroid Use

Negative feedback of androgens on


the hypothamic-pituitary axis
-ve
GnRH
FSH LH

Discontinuation of anabolic steroid


use may restore fertility.

Patients may need therapeutic


intervention to recover fertility in
heavy users.
Tubal problems (Ductus deferens)
Obstructive Azoospermia

Obstruction of the ductal system is responsible for ~


40% of infertility cases

Normal size testes and normal serum FSH levels.

The obstruction is total and either intra-testicular,


in the rete testis, or extra-testicular, in the
epididymis, vas deferens or ejaculatory duct.
Obstructive Azoospermia

May result from:

• Epididymal, vasal, or ejaculatory duct pathology


• Surgery (Vasectomy)
• Genitourinary infections,
• Iatrogenic injury during scrotal or inguinal surgical procedures
• Congenital anomalies (congenital bilateral absence of the vas
deferens (CBAVD))
• Cystic fibrosis

Treatment: Surgical Sperm Retrieval and ICSI


Sexual and /or Ejaculatory Dysfunction

Relationship problems

Infrequent sexual intercourse

Semen allergies

Lack of experience!

Premature ejaculation

Erectile dysfunction

Retrograde ejaculation
Summary of male factor infertility

• Sperm
• Semen analysis and markers of good sperm health
• Causes of poor sperm health
• Testes and Tubes
• Injury
• Infection
• Varicocele
Further reading
• https://www.ncbi.nlm.nih.gov/books/NBK279145/

• Papers on Moodle
Disorders of uterine function in pregnancy
and labour
The uterus

• Smooth muscle
• Myogenic

➢ 50% have/had one


➢ 100% were ‘in’ one
Uterine contractions are important for multiple reproductive
functions

Menstruation Labour

Pregnancy

Conception Delivery
(Baby Eve)
Uterine (myometrial) contractions

How does the myometrium contract?

- What proteins are involved?

- What signalling pathways are activated?

- What initiates contraction?

- How can we regulate contractions?


Physiological basis of myometrial contraction
- From excitation to contraction: Excitation-Contraction Coupling (ECC)
We need:

Depolarization
? Vm
A stimulus

A signalling messenger

Myofilament activation

? Smooth muscle cell

Contraction
Physiological basis of myometrial contraction
- From excitation to contraction: Excitation-Contraction Coupling (ECC)
We need:

Depolarization Vm
A stimulus

A signalling messenger
‘Excitation’
Change in Myofilament activation
membrane
potential (Vm)
Smooth muscle cell

Contraction
Physiological basis of myometrial contraction
- From excitation to contraction: Excitation-Contraction Coupling (ECC)

Opening of Voltage Operated We need:


Calcium channels (VOCCs)
Depolarization Vm
A stimulus
Ca2+
A signalling messenger
‘Excitation’ VOCC
Change in Myofilament activation
membrane Ca2+
potential (Vm)
Smooth muscle cell

Contraction
Physiological basis of myometrial contraction
- From excitation to contraction: Excitation-Contraction Coupling (ECC)

Opening of Voltage Operated We need:


Calcium channels
Depolarization Vm
A stimulus
Ca2+
A signalling messenger
‘Excitation’ VOCC
Change in Myofilament activation
membrane Ca2+
potential (Vm) Activation of
Calmodulin Ca-CaM Smooth muscle cell

Contraction
Physiological basis of myometrial contraction
- From excitation to contraction: Excitation-Contraction Coupling (ECC)

Opening of Voltage Operated We need:


Calcium channels
Depolarization Vm
A stimulus
Ca2+
A signalling messenger
‘Excitation’ VOCC
Change in Myofilament activation
membrane Ca2+
potential (Vm) Activation of
Calmodulin Smooth muscle cell
Ca-CaM

Myosin
Activation of MLCP
MLCK
Myosin light chain Myosin-P
kinase + Actin

Contraction
Physiological basis of myometrial contraction
- From excitation to contraction: Excitation Contraction Coupling (ECC)

Opening of Voltage Operated We need:


Calcium channels
Depolarization Vm
A stimulus
Ca2+
A signalling messenger
‘Excitation’ VOCC
Change in Myofilament activation
membrane Ca2+
potential (Vm) Activation of
Calmodulin Smooth muscle cell
Ca-CaM

Myosin
Activation of MLCP
MLCK
Myosin light chain Myosin-P
kinase + Actin

Contraction
Phosphorylation
of Myosin
Physiological basis of myometrial contraction
Excitation Contraction Coupling (ECC)

Depolarization Vm

Ca2+

VOCC

Ca2+

Ca-CaM

Myosin
MLCP
MLCK
Myosin-P
+ Actin

Contraction

Burdyga et al., 2009 EJOGRB


Physiological basis of myometrial contraction
Excitation-Contraction Coupling (ECC)
We need

Stimulus – Action potential


Depolarization Vm

Signalling messenger – Calcium


Ca2+

Myofilament activation - MLCK


VOCC

Ca2+
Smooth muscle cell
Ca-CaM

Myosin
MLCP
MLCK
Myosin-P
+ Actin

Contraction
Physiological basis of myometrial contraction
Excitation-Contraction Coupling (ECC)
We need

Stimulus – Action potential


Depolarization Vm

Signalling messenger – Calcium


Ca2+

Myofilament activation - MLCK


VOCC

Ca2+
Smooth muscle cell
Ca-CaM

Myosin
MLCP
MLCK Communication between
Myosin-P
+ Actin cells - Gap junctions
(Connexin 43)
Contraction
Physiological basis of myometrial contraction
Relaxation We need

De-phosphorylation of Myosin –
MLCP
Depolarization Vm
Ca2+
Ca2+ Ca extrusion/uptake into SR
PMCA (needs ATP)
VOCC
Hyperpolarisation of the Vm
Ca2+ Ca2+
SERCA SR [Ca2+]
Ca-CaM

Myosin Smooth muscle cell


MLCK MLCP
Myosin-P
+ Actin

Relaxation
However…..
- Agonists e.g. hormones can change membrane potential and increase Ca entry

Depolarization Vm
E.g. Oxytocin
GPCR
Ca2+ Gq/11
PLC-β
GPCR
VOCC PIP2 G12/13

IP3 DAG
Ca2+
Ca2+
SR [Ca2+] Effects
Ca-CaM

Myosin
MLCK MLCP
Myosin-P
+ Actin

Contraction
What is oxytocin?
Oxytocin

Maternal Pro-social
behaviour and behaviours
pair bonding

Stress relief
Milk ejection reflex
Oxytocin

Maternal Pro-social
behaviour and behaviours
pair bonding

Stress relief
Milk ejection reflex
Uterine
contraction
Hypothalamus
- supraoptic nuclei
- paraventricular
nuclei

magnocellular
neurons

Anterior Posterior
pituitary pituitary

Prolactin Oxytocin (OT)


FSH, LH, Vasopressin (AVP)
TSH, ACTH, GH
Oxytocin increases [Ca]i in human myometrium

Arrowsmith and Wray 2014, J Neuroendocrinol


Arrowsmith Accepted, Current Opinion in Physiology,
Oxytocin increases [Ca]i in human myometrium: Ca release from the
Sarcoplasmic reticulum

Simultaneous recordings of force and


Ca in myometrial muscle in vitro

Arrowsmith and Wray 2014, J Neuroendocrinol


Arrowsmith 2020, Current Opinion in Physiology,
Oxytocin increases [Ca]i in human myometrium Ca entry mechanisms?

2mMCaCl2
2 100nM
100nM
Force
(mN) Removing external Ca,
0
1.2
significantly reduces
F 400/500
oxytocin’s action
(Calcium)

0.8 20min

Arrowsmith and Wray 2014, J Neuroendocrinol


Arrowsmith 2020, Current Opinion in Physiology,
Oxytocin increases [Ca]i in human myometrium Ca entry mechanisms?

2mMCaCl2
2 100nM
100nM
Force
(mN)
0
1.2

F 400/500
(Calcium)

0.8 20min

Arrowsmith and Wray 2014, J Neuroendocrinol


Arrowsmith 2020, Current Opinion in Physiology,
Oxytocin increases [Ca]i in human myometrium Ca entry mechanisms?

Through VOCCs YES!

2mMCaCl2
2 100nM
100nM
Force
(mN)
0
1.2

F 400/500
(Calcium)

0.8 20min

Arrowsmith and Wray 2014, J Neuroendocrinol


Arrowsmith 2020, Current Opinion in Physiology,
Oxytocin increases [Ca]i in human myometrium
Ca entry mechanisms?

YES!

2mMCaCl2
2 100nM
100nM
Force
(mN)
0
1.2

F 400/500
(Calcium)

0.8 20min

Via Store-
operated Ca entry
Arrowsmith and Wray 2014, J Neuroendocrinol
Arrowsmith 2020, Current Opinion in Physiology,
Oxytocin increases [Ca]i in human myometrium Ca entry mechanisms?

YES!

2mMCaCl2
2 100nM
100nM
Force
(mN)
0
1.2

F 400/500
(Calcium)

0.8 20min

Via Store-
operated Ca entry
Arrowsmith and Wray 2014, J Neuroendocrinol
Arrowsmith 2020, Current Opinion in Physiology,
Oxytocin changes Ca sensitivity in human myometrium

Increases force of contraction


without a change in [Ca]i

Phosphorylation of MLCP,
inactivates it

Myosin is phosphorylated
independently of a change
in Ca

Questions? Arrowsmith and Wray 2014, J Neuroendocrinol


Arrowsmith 2020, Current Opinion in Physiology,
So now we know how the myometrium
contracts….

What’s next?
Uterine contractions are important for multiple
reproductive functions

Menstruation Labour

Pregnancy

Conception Delivery
(Baby Eve)
Uterine contractions are important for multiple
reproductive functions

Removal of menses

Retrograde menstruation / cervico fundal contractions → endometriosis?

Peristalsis mid cycle and trauma induced injury and repair model of
adenomyosis ?
Menstruation
oxytocin

Arch Gynecol Obstet (2009) 280:529–538 DOI 10.1007/s00404-009-1191-0


Recent data suggests adenomyosis is linked to
infertility in mice via aberrant Ca signalling and
uterine peristalsis
Uterine contractions are important for multiple
reproductive functions

Removal of menses:

Retrograde menstruation / cervico fundal contractions → endometriosis?

Peristalsis mid cycle and trauma induced injury and repair model of
adenomyosis ?
Menstruation

Sperm transport towards the fallopian tubes:

Cervico-fundal contractions (peristalsis)

Overactive peristalsis and poor implantation?

Conception
Uterine contractions are important for multiple
reproductive functions

Menstruation Labour

Pregnancy

Conception Delivery
(Baby Eve)
The myometrium in pregnancy

Role:
• To house and support the growing fetus, placenta and membranes
• To grow and stretch to accommodate the growing fetus (hypertrophy
and hyperplasia)

• To stay quiescent
Until……
The myometrium and parturition*
* Expulsion of the fetus from the uterus through the cervix and vagina
1.
3 Stages:

1. Dilation stage – onset of labour, cervical dilation


and thinning, membranes rupture? (waters break)
2.

2. Expulsion stage – cervix dilates to 10cm,


contractions reach max intensity, baby is delivered

3. Placental stage (afterbirth)– uterine contractions


3.
detach the placenta from the endometrium and
placenta is expelled
The challenges:
~300,000 women die each year from complications of pregnancy /childbirth1
>50% uterine contractility problems

10% of births (15M) are preterm → neonatal death and disability


~75% spontaneous labour onset (contractions occur too early)

10 babies stillborn every day in UK (4 in 1000 births)2


- contractions are too strong, cause fetal distress

100,000 unplanned operations (EmCS) carried out p.a (16%)3


for dysfunctional labour/poor contractions

10% incidence of obstetric haemorrhage – leading cause of maternal death4


~70% due to poor contractility/uterine atony

(1) WH0, 2019; (2) ONS, Births in E&W 2020; (3, 4) Maternity services, NHS digital;
Pre-term labour Prolonged/
dysfunctional labour
Neonatal death,
Exhaustion,
Neurological sequalae
Need for CS

Caesarean section
delivery

Fetal distress Infection


Repeat CS
Still birth,
Hypoxic damage
Need for Caesarean section Post-partum complications
Post-partum haemorrhage,
Maternal death,
➢ All involve uterine muscular activity Hysterectomy
➢ Aberrant timing or strength of contractions
What initiates labour…?

?
Initiation of labour and delivery…..a complex story!

Placental factors Fetal factors


Estrogen Relaxin Cervical Fetal growth
CRH dilatation Fetal pituitary

Stretch of the
myometrium
+
Maternal oxytocin Prostaglandin production
release
+
+ Increased excitability of the myometrium

Labour contractions
Initiation of labour

CRH (Corticotrophin releasing hormone)

• Produced in placenta and released into CRH


mothers circulation
• CRH levels exponentially rise towards
term…placental clock?
• In fetus, acts on fetal adrenal gland to
release DHEA, the precursor for
placental estrogen
Initiation of labour

Estrogen

• Estrogen promotes increased sensitivity


of the myometrium to oxytocin and
increases its excitability via gap
junctions
Initiation of labour

Progesterone (P4)

• Despite being the pro-gestational


hormone, there is NO decrease in P4
levels in humans

• ‘Functional’ progesterone withdrawal


involving changes in P4 receptor
isoform expression
Plasma P4 levels in mice decrease significantly
prior to labour onset
Labour and uterine contractions
 Estrogen
1. Dilatation of cervix
2. Powerful, co-ordinated uterine contractions  Oxytocin receptors in  Uterine responsiveness to
myometrium low levels of oxytocin
START : ~30 secs, every 30 mins.
END: ~1-2mins, every 2-3 mins.  Uterine
contractions
POSITIVE feedback involving oxytocin

NEUROENDOCRINE REFLEX (Ferguson reflex)  Pressure/stretch


Stretching of the cervix causes nerve impulses sent to + at cervix from fetus

brain stimulating posterior pituitary production of


oxytocin, further stimulating contraction and enabling Neuroendocrine
reflex
labour to progress.
 Oxytocin 
secretion Prostaglandin
Posterior pituitary production
Labour progression: A positive feedback loop

of

NEUROENDOCRINE REFLEX
Bringing it all together…

Placental factors Fetal factors


Estrogen Relaxin Cervical Fetal growth
CRH dilatation Fetal pituitary

Stretch of the
cervix/myometrium
+
Maternal oxytocin Prostaglandin production
release
+
+ Increased excitability of the myometrium

Labour contractions
So what can (and does) go wrong….?
Preterm birth:

• Delivery of the fetus before 37 weeks gestation

• Sub-categories of preterm birth, based on gestational age:

• extremely preterm (less than 28 weeks)

• very preterm (28 to 32 weeks)

• moderate to late preterm (32 to 37 weeks)


The toll of preterm birth

www.who.int/mediacentre/factsheets/fs363
The toll of preterm birth

• 75% are ‘spontaneous’ preterm birth


• Premature rupture of membranes (PPROM)
• Preterm labour onset

• Increased neonatal morbidity and mortality


• sepsis,
• intraventricular hemorrhage,
• necrotizing enterocolitis
• respiratory distress syndrome

• Reduced lifelong achievement in survivors


Aetiology of preterm labour onset?

Uterine
contraction

Fetal
Cervical membrane
ripening rupture
Aetiology of preterm labour onset?

Uterine
contraction

Fetal
Cervical membrane
ripening rupture
Aetiology of ‘normal’ labour onset- role of inflammation

Uterine quiescence Uterine activation

Progesterone
Inflammatory signalling
PR-A/B ratio
Cytokines, chemokines
Oxytocin receptor
Gap junctions

Cervical ripening
Membrane rupture
Uterine contraction
Aetiology of ‘normal’ labour onset- role of inflammation

Uterine quiescence Uterine activation


macrophages
Progesterone
neutrophils Inflammatory signalling
PR-A/B ratio
Cytokines, chemokines
Oxytocin receptor
Gap junctions

Cervical ripening
Membrane rupture
Uterine contraction
Aetiology of ‘normal’ labour onset- role of inflammation

Uterine quiescence Uterine activation


macrophages
Progesterone
neutrophils Inflammatory signalling
PR-A/B ratio
Cytokines, chemokines
Oxytocin receptor
Fetus/placenta Gap junctions

CRH
Surfactant
Stretch
Cervical ripening
Membrane rupture
Uterine contraction
Aetiology of preterm labour onset – aberrant inflammation?

Uterine quiescence Uterine activation


macrophages
Progesterone
neutrophils Inflammatory signalling
PR-A/B ratio
Cytokines, chemokines
Oxytocin receptor
Fetus/placenta Gap junctions

CRH
Surfactant
Stretch
Cervical ripening
Membrane rupture

PRETERM uterine contraction


The aetiology of preterm birth

?
Preterm birth: Treatment

Knowing what you know about myometrial


contractions,

how could you inhibit them?


Dysfunctional labour - dystocia
Dysfunctional labour - dystocia

Knowing what you know about myometrial


contractions,

how could you augment them?


‘Womens’ problems’

Heart failure or CVD Labour dystocia


(uterine failure)

~ 50 drugs 1 ‘drug’

Pharmacopeia
‘Womens’ problems’
Preterm
Heart failure or CVD
contractions
Nifedipine
Ritodrine (β2-AR)
~ 50 drugs ~5 drugs MgSO4
Indomethacin
Atosiban

Pharmacopeia
Post-Partum Haemorrhage (PPH)
• The most common form of major obstetric haemorrhage

• The second leading direct cause of maternal deaths in the UK and the leading cause of
maternal mortality in the world

• Traditional definition:

‘the loss of 500 ml or more of blood from the genital tract after the delivery of the
fetus’ (or 1000 ml following Caesarean delivery)

• Primary postpartum haemorrhage occurs within the first 24 hours of delivery

• Secondary postpartum haemorrhage occurs between 24 hours and 12 weeks after delivery

RCOG 2016, BMJ 2017


PPH Cause
• Poor uterine tone (failure to contract) accounts for about 80% of all cases of primary
postpartum haemorrhage*,

Stage 3: Placental stage (afterbirth)– uterine


contractions detach the placenta from the
endometrium and placenta is expelled

• The blood flow to the uterus at term (>37 weeks of gestation) is approximately 1000 mL of
blood every minute, and a fetus at term receives about 200 mL/kg/minute from the
placenta**

• Endometritis is the commonest cause of secondary postpartum haemorrhage presenting


up to 12 weeks after delivery
*Arulkumaran S.. Curr Obstet Gynaecol1999;9:101-5.
**Ferrazzi E, Placenta2011;32:487-92
PPH management
Serious maternal morbidities include multiorgan failure, multiple blood transfusion, and peripartum hysterectomy

• Active management of the third stage of labour


• Expulsion of the placenta and membranes after delivery by uterine massage
• Controlled cord traction
• Use of drugs to aid uterine contraction WHICH DRUGS?

Oxytocin is the most commonly used drug in the medical management of postpartum haemorrhage

Ergometrine (ergot alkaloid) - First line drug in developing countries - Arterial vasoconstriction and myometrial contraction

Tranexamic acid - Antifibrinolytic (stabilises clotting)

Prostaglandins F2α OR Misoprostol (prostaglandin analogue) – myometrial contraction

Carbetocin (synthetic oxytocin analogue)

Syntometrine (combination of oxytocin and ergometrine)


Summary- uterine contractions

• Physiological pathways responsible for uterine contraction and its relaxation


including Excitation contraction coupling

• Disorders of contraction including


• Adenomyosis,
• Preterm birth,
• Labour dystocia and PPH

• Causes of Preterm birth and potential treatment strategies


• Dysfunctional labour, PPH and treatment strategies
Further Reading

Papers on Moodle

For physiology of contractions:

‘Insights into the Uterus’ by Wray 2007

‘Physiological pathways and molecular mechanisms regulating uterine contractility by Aguilar and
Mitchell 2010

You might also like